Get medical help if the Cream17 study did not report serious side effects during 4 weeks of use, suggesting short-term used on the skin tolerability in the studied adult population, though details on minor irritation.
Ingredient
Safety not yet rated
Multi Herb Topical Cream17 Composition Uncertain
A randomized assessor-blinded 4-week trial of a topical cream containing 17% herbal extract (Cream17) in 33 subjects showed significant reductions in transepidermal water loss (TEWL) and significant increases in skin water content compared with untreated control, indicating improved skin barrier function relevant to dry-skin conditions. In the Cream17 trial, topical application significantly lowered itch scores at 2 and 4 weeks compared with untreated control, aligning with symptomatic relief of pruritus associated with dry skin.
Reviewed health uses
Household preparations
Safety information
The Cream17 study did not report serious adverse events during 4 weeks of use, suggesting short-term topical tolerability in the studied adult population, though details on minor irritation or long-term safety are limited.